Development of a multivariate model to predict clinical deterioration in pulmonary sarcoidosis

Conclusions: We believe this is the first study to demonstrate the prognostic value of ALP and albumin in predicting decline in pulmonary sarcoidosis. Interestingly, MRC breathlessness score outperformed baseline DLCO in this model. We plan to remove confounders such as treatment and validate our model in a second cohort of patients presenting to a separate clinic. Further validation of this model may assist in decisions of when to initiate treatment.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Diffuse Parenchymal Lung Disease Source Type: research